TrialBritish journal of cancer2013

A randomised, placebo-controlled, double-blind study of aprepitant in nondrinking women younger than 70 years receiving moderately emetogenic chemotherapy.

M Tanioka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.